MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Personalized Optimization of Deep Brain Stimulation Parameters for Gait Enhancement in Parkinson’s Disease: A Data-Driven Approach

    H. Fekri Azgomi, K. Louie, J. Bath, J. Balakid, J. Marks, D. Wang (San Francisco, USA)

    Objective: Our goal is to develop a data-driven approach to identify optimal Deep brain stimulation (DBS) parameters for gait enhancement in patients with Parkinson's disease…
  • 2024 International Congress

    Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease

    T. Fitzgerald, C. O'Keeffe, J. Inocentes, E. Murphy, M. Bradley, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…
  • 2024 International Congress

    Altered gut microbiota composition and metabolism in Parkinson’s disease

    D. Mondhe, K. Roper, N. Jayabalan, J. O'Sullivan, R. Adam, A. Lehn, R. Gordon (Brisbane, Australia)

    Objective: To define changes in gut microbiota composition and metabolism to enable identification of novel therapeutic targets and strategies for disease modification. Background: Multiple cohort…
  • 2024 International Congress

    Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease

    G. Legerme, D. Nolasco, A. Sohel, A. Wu, B. Carr (Gainesville, USA)

    Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…
  • 2024 International Congress

    Differentiating the Local Field Potential Oscillations in Low and Beta Range in Parkinson`s and Dystonic Movement Disorder

    S. Konda, R. Venkateshwara, K. Balmuri (Hyderabad, India)

    Objective: To framework the novel data of subcortical oscillations in Parkinson`s and dystonic patients for the comparison of local field oscillatory (low, beta) influence amongst…
  • 2024 International Congress

    Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease

    A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

    Objective: The objective of our study is to determine whether differences in oculomotor function and blink rate correlate to the off-and on- medication state in a cohort of…
  • 2024 International Congress

    Improving awareness of motor fluctuations in Parkinson’s Disease: an educational patient support program using a waist-worn device.

    N. Caballol, A. ávila, A. Planas-Ballvé, A. Peral, J. Hernández-Vara, S. Belmonte, S. Enríquez, S. Sánchez, D. Cerdán, I. Cabo, N. López-Ariztegui, G. Carvalho, JM. Velázquez, T. Delgado, J. Bocos, B. Ruiz, B. Claramonte, J. Herreros-Rodríguez, D. Santos-García, C. Cores-Bartolomé, J. González-Ardura, D. Ceberino, JM. Salom, R. Rashid, A. Méndez, C. Madrid-Navarro, A. Mulet, D. Rodríguez-Martín, I. Pijuan, I. Tegel (Sant Joan Despí, Spain)

    Objective: To describe the utility of an educational patient support program designed to improve awareness of motor fluctuations (MF) and provide education on motor and…
  • 2024 International Congress

    Addressing Patient Needs: Enhancing Patient-Centered Care at the Movement Disorders Center

    M. Ivancic, A. Frohlich, W. Crutchfield, H. Morita, R. Murrow, J. Rider, D. Roque, M. Sklerov, C. Testa, J. Younce, N. Browner (Chapel Hill, USA)

    Objective: To define patients’ needs and enhance educational and quality improvement initiatives at our center. Background: Patient-centered care is critical for the managing the symptoms…
  • 2024 International Congress

    Predictors of Response to Botulinum Toxin Treatment in Patients With Hemifacial Spasm:A Prospective Study

    S. Jain, S. Pandey, RK. Garg, HS. Malhotra, I. Rizvi (Lucknow, India)

    Objective: To study the predictors of Good and Bad outcome and the impact on quality of life of patients with HFS following Botulinum toxin treatment.…
  • 2024 International Congress

    Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis

    N. Xia, J. Ripping, R. Bakshi, E. Macklin, S. Molsberry, X. Chen, A. Ascherio, M. Schwarzschild (Charlestown, USA)

    Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…
  • « Previous Page
  • 1
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley